Centro informazioni
ヤンセンが取りあげられたニュース
プレスリリース
9月 20, 2024
Belgium
DARZALEX® (daratumumab)-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma
9月 19, 2024
United States
RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U.S. as first and only targeted regimen to cut risk of disease progression by more than half in second-line EGFR-mutated advanced lung cancer
9月 15, 2024
Spain
New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
閉じる
アートギャラリー
ヤンセンが治療と予防に携わっている病気や疾患を持つ方々のアート作品をご紹介できることを光栄に思います。
ギャラリーを見るMartin Freeman, Not What It's Cracked Up to Be